Weekly Executive & Director Moves (Sep 9)

by | Sep 9, 2022

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Moves in this Issue

CEO

AMCX, ATUS, FIXX, KOPN, LFST, MDXG, SPNT, SSD, VCSA

CFO

ARW, AVT, BXSL, CADL, CAL, FRPT, HGTY, IPAR, MRNA, NATR, OLED, OSPN, PAY, TFC, VYGR

Directors

AAL, ABM, AON, ARQT, CLH, CNM, CSGS, DAKT, ELAN, EOSE, FIXX, GERN, GO, HLGN, IDCC, JELD, LAZY, LCAA, LFST, NPO, OVV, PTE, RBBN, RKLB, SPNT, SQZ, SSD, THO, THR, UFI, VCSA, WBA, XNCR

CEO Moves

AMC NETWORKS INC (AMCX)
Leaving: CEO – Matthew Blank ( 1.0 yrs; -41.8% TSR)
Replaced by: Christina Spade

CHRISTINA SPADE Age: 53 Chief Operating Officer and Chief Financial Officer of the Company since November 22, 2021. She previously served as Executive Vice President, Chief Financial Officer of the Company from January 15, 2021 until her promotion on November 22, 2021. Ms. Spade was Executive Vice President, Chief Financial Officer of ViacomCBS Inc. (formerly, CBS Corporation, which is the survivi…read full bio

HOMOLOGY MEDICINES INC (FIXX)
Leaving: CEO – Arthur Tzianabos ( 6.4 yrs; -35.6% TSR)
Replaced by: Albert Seymour

Albert Seymour, Ph.D. has served as our President since April 2022 and as our Chief Scientific Officer since April 2016. Prior to joining Homology, Dr. Seymour was Senior Vice President, Head of Global Research and Nonclinical Development at Shire plc, a biotechnology company, from 2011 to 2016. Since February 2021, Dr. Seymour has served on the board of directors of Ensoma Inc., a private gene th…read full bio

LIFESTANCE HEALTH GROUP INC (LFST)
Leaving: CEO – Michael K Lester ( 1.3 yrs; -64.6% TSR)
Replaced by: Kenneth A Burdick

Mr. Burdick joined WellCare in 2014, serving initially as President, National Health Plans and then as President and Chief Operating Officer. He served as the President and Chief Executive Officer of Blue Cross and Blue Shield of Minnesota from February 2012 to July 2012. From August 2010 to February 2012, he served as Chief Executive Officer of the Medicaid and Behavioral Health businesses of Cov…read full bio

MIMEDX GROUP INC (MDXG)
Leaving: CEO – Timothy R Wright ( 3.3 yrs; 5.2% TSR)
Replaced by: Todd Newton

Mr. Newton will serve in such capacity on an interim basis until a successor is identified and appointed and will continue to serve on the board of directors of the Company. Pursuant to the terms of the Letter Agreement between the Company and Mr. Wright, dated as of April 8, 2019, Mr. Wright also ceased to be a member of the board of directors effective upon the termination of his employment as C…read full bio


SIRIUSPOINT LTD (SPNT)
Leaving: CEO – Daniel V Malloy ( .3 yrs; -14.8% TSR)
Replaced by: Scott Egan

Mr. Egan’s start date is expected to be on or about September 21, 2022 (the ” Effective Date “). Mr. Egan will succeed Daniel V. Malloy, who has served as the Company’s Interim Chief Executive Officer since May 2022. Mr. Egan, age 51, previously served as the Chief Executive Officer, UK & International Division of RSA Insurance Group Limited, a British multinational general insurance company (” RS…read full bio

VACASA INC (VCSA)
Leaving: CEO – Matthew Roberts ( .8 yrs; -63.1% TSR)
Replaced by: Robert W. Greyber

Mr. Greyber, age 52, previously held various senior level positions with Expedia Group and with Egencia, a leading digital corporate travel platform previously owned by Expedia Group from March 2004 to April 2020, including most recently as Egencia’s President from May 2009 to April 2020 where he was responsible for Egencia’s global strategy, brand, technology and…read full bio

CFO Moves

ARROW ELECTRONICS INC (ARW)
Leaving: CFO – Richard A Seidlitz ( .4 yrs; -21.0% TSR)
Replaced by: Rajesh K Agrawal

Mr. Agrawal also currently serves on the Board of Directors, and the Audit and Risk Committee and Remuneration Committee, of Beazley PLC. Mr. Agrawal holds a Master of Business Administration from Columbia University and a Bachelor of Science degree in engineering from the GMI Engineering & Management Institute, renamed Kettering University in 1997. In connection with his appointment, Mr. Agrawal …read full bio

AVNET INC (AVT)
Leaving: CFO – Thomas Liguori ( 4.7 yrs; 4.4% TSR)
Replaced by: Kenneth A Jacobson

Mr. Jacobson, age 44, has served as the Company’s Controller since 2013 and Principal Accounting Officer since February 2018. From August 2017 to January 2018, he served as the Interim Chief Financial Officer. Prior to joining the Company, Mr. Jacobson served as the Director of External Reporting and Accounting Research for First Solar Inc. from 2011 to 2013, where he led external reporting and pr…read full bio

BLACKSTONE SECURED LENDING FUND (BXSL)
Leaving: CFO – Stephan Kuppenheimer ( 3.8 yrs; -9.7% TSR)
Replaced by: Kevin Kresge

Mr. Kresge, born 1983, is a Managing Director and Head of Finance for Blackstone Credit, Blackstone’s credit investment platform. At Blackstone Credit, Mr. Kresge is responsible for valuations, financial planning and analysis, expense management and financial reporting.

Prior to joining Blackstone Credit, Mr. Kresge served as Chief Financial Officer of the Private We…read full bio

CANDEL THERAPEUTICS INC (CADL)
Leaving: CFO – John J Canepa ( 1.2 yrs; -46.8% TSR)
Replaced by: Jason Amello

Mr. Amello, age 53, previously served as Chief Financial Officer and Treasurer of Saniona AB (Nasdaq Stockholm: SANION) from September 2020 to April 2022. Prior to that, Mr. Amello served as Senior Vice President, Chief Financial Officer and Treasurer of Akebia Therapeutics, Inc. (Nasdaq: AKBA) from September 2013 to August 2020. Mr. Amello was also Executive Vice President, Chief Financial Office…read full bio

HAGERTY INC (HGTY)
Leaving: CFO – Frederick Turcotte ( .8 yrs; 23.3% TSR)
Replaced by: Patrick McClymont

Mr. McClymont, age 52, served as the Chief Financial Officer of Orchard Technologies, Inc., a residential real estate services company from 2021 through August 2022. Mr. McClymont was previously the Executive Vice President and Chief Financial Officer of Imax Corporation (NYSE: IMAX) from 2016 through 2021. Mr. McClymont was responsible for all aspects of Imax’s finance related functions including…read full bio

INTER PARFUMS INC (IPAR)
Leaving: CFO – Russell Greenberg ( 30.3 yrs; 17.5% TSR)
Replaced by: Michel Atwood

Michel Atwood Mr. Atwood, age 52, currently resides in New York City, and will become our Chief Financial Officer on September 6, 2022. From September 2018 through March 2022 while at Estee Lauder, Mr. Atwood had strategic oversight for the fragrance category across that company and operational accountability for several of its fragrance brands. He also had senior level merger and acquisition (“M&…read full bio

ONESPAN INC (OSPN)
Leaving: CFO – Jan Kees Van Gaalen ( .9 yrs; -40.4% TSR)
Replaced by: Jorge Garcia Martell

Mr. Martell, age 44, joins the Company from Extreme Reach, Inc., an omnichannel creative logistics company for brand advertising, where he served as Chief Financial Officer and Treasurer from July 2016 to September 2022 and as Vice President of Finance, Corporate Controller, from April 2015 to July 2016. Prior to that, Martell was Director of Finance, Treasurer and Assistant Corporate Controlle…read full bio

PAYMENTUS HOLDINGS INC (PAY)
Leaving: CFO – Matt Parson ( 1.3 yrs; -50.1% TSR)
Replaced by: Paul Seamon

Prior to joining the Company, Mr. Seamon served as Executive Vice President of Finance at Alight Solutions, a human resources technology company, from 2018 to 2020. Previously, he served in various roles in corporate development, strategy and finance from 2006 to 2018 at Fiserv, a provider of financial technology solutions, most recently as Vice President of Investor Relations. From 2004 to 200…read full bio

TRUIST FINANCIAL CORP (TFC)
Leaving: CFO – Daryl N Bible ( 13.7 yrs; 7.7% TSR)
Replaced by: Michael Baron Maguire

Mr. Maguire, age 44, will succeed Daryl N. Bible, who announced in May 2022 that he planned to retire from Truist upon the naming and transition of his successor. Since December 2019, Mr. Maguire has served as Chief Consumer Finance and Payments Officer of Truist, leading the company’s consumer finance businesses, including LightStream, Service Finance, Sheffield Financial, Dealer Retail Services,…read full bio

UNIVERSAL DISPLAY CORP (OLED)
Leaving: CFO – Sidney D Rosenblatt ( 27.3 yrs; 14.0% TSR)
Replaced by: Brian Millard

Prior to being hired by the Company, Mr. Millard was serving as Senior Vice President of Finance and Corporate Controller at Emergent BioSolutions. Prior to Emergent, Mr. Millard served as Vice President and Corporate Controller at Hertz Global Holdings. He also held financial reporting positions at Hilton Worldwide and began his professional career at Deloitte & Touche. Mr. Millard has a M…read full bio

VOYAGER THERAPEUTICS INC (VYGR)
Leaving: CFO – Julie Burek ( .8 yrs; 66.0% TSR)
Replaced by: Peter P Pfreundschuh

Mr. Pfreundschuh, age 53, previously served as Chief Financial Officer of Frequency Therapeutics, Inc., a biotechnology company, from December 2020 to April 2022. Prior to joining Frequency, Mr. Pfreundschuh served as Chief Financial Officer, Chief Compliance Officer and Corporate Secretary of UroGen Pharma Ltd., a commercial-stage biopharma company, from August 2018 to October 2020. Prior to join…read full bio

Director Joins

ARCUTIS BIOTHERAPEUTICS INC (ARQT)
Neha Krishnamohan

Ms. Krishnamohan’s term as director will expire at the 2023 annual meeting of stockholders or until her successor is elected and qualified or her earlier resignation, disqualification, retirement, removal or death. Ms. Krishnamohan has served as Chief Financial Officer and Executive Vice President, …read full bio

CORE & MAIN INC (CNM)
Robert M Buck

Mr. Buck was also appointed as a member of the Compensation Committee of the Board. Mr. Buck will hold office until the 2024 annual general meeting of stockholders or until removed from office in accordance with the Company’s amended and restated certificate of incorporation. There was no arrangemen…read full bio

CSG SYSTEMS INTERNATIONAL INC (CSGS)
Rachel A. Barger

Ms. Barger has been at Cisco Systems, Inc. since October 2020, and in May of 2022 was named Senior Vice President, Americas Sales responsible for overseeing the largest of the company’s three sales geographies with over 5,000 employees across 17 countries. She served as a President an…read full bio

ENPRO INDUSTRIES INC (NPO)
William Abbey

Mr. Abbey brings to Enpro more than 25 years of experience in the semiconductor industry and a deep knowledge of the evolving global semiconductor ecosystem.  Mr. Abbey currently serves as Senior Vice President of Sales and Partner Enablement at global semiconductor leader Arm, owned by So…read full bio

HOMOLOGY MEDICINES INC (FIXX)
Albert Seymour

Albert Seymour, Ph.D. has served as our President since April 2022 and as our Chief Scientific Officer since April 2016. Prior to joining Homology, Dr. Seymour was Senior Vice President, Head of Global Research and Nonclinical Development at Shire plc, a biotechnology company, from 2011 to 2016. Sin…read full bio

LAZYDAYS HOLDINGS INC (LAZY)
John F North

Mr. North has served as senior vice president and chief financial officer at Copart, Inc. (Nasdaq: CPRT), a leading provider of online auctions and vehicle remarketing services, since October 2020. Prior to that, Mr. North served as the chief financial officer of Avis Budget Group, Inc. (Nasdaq: …read full bio

LIFESTANCE HEALTH GROUP INC (LFST)
Kenneth A Burdick

Mr. Burdick joined WellCare in 2014, serving initially as President, National Health Plans and then as President and Chief Operating Officer. He served as the President and Chief Executive Officer of Blue Cross and Blue Shield of Minnesota from February 2012 to July 2012. From August 2010 to Februar…read full bio

SIRIUSPOINT LTD (SPNT)
Scott Egan

Mr. Egan’s start date is expected to be on or about September 21, 2022 (the ” Effective Date “). Mr. Egan will succeed Daniel V. Malloy, who has served as the Company’s Interim Chief Executive Officer since May 2022. Mr. Egan, age 51, previously served as the Chief Executive Officer, UK & Internatio…read full bio

SQZ BIOTECHNOLOGIES CO (SQZ)
Howard Bernstein

Dr. Bernstein will serve as a Class I director until the 2024 annual meeting of stockholders or until his successor has been duly elected and qualified or until his earlier death, resignation or removal. The Board determined that Dr. Bernstein is not independent under the applicable rules of NYSE. A…read full bio

THERMON GROUP HOLDINGS INC (THR)
Angela Strzelecki

Dr. Strzelecki is appointed to serve as directors until the Company’s next annual meeting of stockholders in 2023. Effective as of September 6, 2022, Dr. Strzelecki has also been appointed to serve on the Finance, Human Capital Management and Compensation, and Nominating and Corporate Governance Com…read full bio

VACASA INC (VCSA)
Robert W. Greyber

Mr. Greyber, age 52, previously held various senior level positions with Expedia Group and with Egencia, a leading digital corporate travel platform previously owned by Expedia Group from March 2004 to April 2020, including most recently as Egencia’s President from May 2009 to…read full bio

Director Exits

DAKTRONICS INC (DAKT)
James B Morgan ( 38.7 yrs; 9.4% TSR)
Committees: Audit, Nominating (and Governance)

ELANCO ANIMAL HEALTH INC (ELAN)
Scott D Ferguson ( 1.8 yrs; -28.0% TSR)
Committees: Finance and Oversight

GROCERY OUTLET HOLDING CORP (GO)
S Macgregor Read Jr ( 16.7 yrs; 8.7% TSR)

HELIOGEN INC (HLGN)
David Crane ( -81.4% TSR)

LIFESTANCE HEALTH GROUP INC (LFST)
Michael K Lester ( 1.3 yrs; -64.6% TSR)

POLARITYTE INC (PTE)
Jeffrey Hansen Dyer ( 5.5 yrs; -56.9% TSR)
Committees: Audit, Compensation, Nominating (and Governance)

SIMPSON MANUFACTURING CO INC (SSD)
Karen Winifred Colonias ( 9.9 yrs; 15.9% TSR)
Committees: Corporate Strategy and Acquisitions

THOR INDUSTRIES INC (THO)
James L Ziemer ( 11.8 yrs; 10.9% TSR)
Committees: Audit, Environmental, Social, Governance and Nominating, Nominating (and Governance)

VACASA INC (VCSA)
Matthew Roberts ( .8 yrs; -63.1% TSR)

XENCOR INC (XNCR)
Yujiro S Hata ( 7.2 yrs; 4.8% TSR)
Committees: Audit, Nominating (and Governance)

<a href="https://www.boardroomalpha.com/author/draps/" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

More from Boardroom Alpha

SPAC Daily: Tuesday 9/14

Maxpro Acquisition (JMAC) penned the lone SPAC DA of the day, plus the rest of today’s news in the market.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed. 

Executive Moves

Newsletter

Get it in your inbox weekly and don't miss a move